Leiner Expands OTC Portfolio With Phenylephrine HCl, Ibuprofen Offerings
This article was originally published in The Tan Sheet
Executive Summary
Leiner plans to launch phenylephrine HCl 10 mg - a "next option" nasal decongestant - in early 2005 to reach an untapped market, the firm announced at the PLMA trade show in Chicago Nov. 14-16
You may also be interested in...
Pfizer Eyes Consumer Unit Spin-Off Or Sale Price North of $10 Bil.
Pfizer has "no interest" in separately divesting individual products from its consumer division, CEO Hank McKinnell said during a Feb. 10 analysts presentation
Replacing Pseudoephedrine Easier Said Than Done, OTC Firms Find
Reformulating pseudoephedrine products has posed a greater challenge than expected for a number of firms, as passage of a federal bill restricting sale of the ingredient looms
Pfizer Eyes Consumer Unit Spin-Off Or Sale Price North of $10 Bil.
Pfizer has "no interest" in separately divesting individual products from its consumer division, CEO Hank McKinnell said during a Feb. 10 analysts presentation